Colossal adds $120M to its Series C, reaching a $10.3B valuation, and grows pigeon germ cells toward a dodo

Colossal Biosciences

Colossal added $120M from USIT, Bob Nelsen and Peter Jackson to its $200M Series C, making the round $320M and total funding just over $555M at a $10.32B valuation. It also reported growing pigeon primordial germ cells in the lab for the first time, a step toward making dodo-like birds.